Cirrus, a Kemwell company based in Research Triangle Park, North Carolina is a contract research and product development company that partners with biotechnology and pharmaceutical companies on dosage form development projects. With partnerships that span the globe, Cirrus works with start-up, mid-size and multinational companies. We can assist or manage projects as needed by providing a broad array of R&D services including physical and chemical characterization, formulation development, stability testing, container/closure selection, process development, scale-up and technical transfer to manufacturing for inhaled, oral, topical and parenteral products. Services can include submission-ready regulatory documentation and assistance with regulatory submission questions.
Dr. Anthony Hickey and Dr. Jean-Marc Bovet founded Cirrus in 1997. In 2013, Kemwell Biopharma Pvt. Ltd, a Bangalore-based leading provider of formulations contract manufacturing and development services, acquired the Cirrus facility and added it to their global portfolio. From facilities in India and Sweden, Kemwell manufactures tablets, capsules, liquid orals, external drops, ointments, gels and creams. Kemwell’s customers include 5 of the top 10 pharmaceutical companies in the world, manufacturing 5 of the top 10 brands in India. Kemwell’s Pharmaceutical Development Unit provides services in clinical manufacturing and packaging, formulation and analytical development, stability studies, regulatory documentation etc. With a 100% commitment to pure play contract manufacturing, Kemwell has no branded products of its own in the market, thereby avoiding any conflict of interests with its customers.
Our success is largely due to our focus on timely research and project development support to the pharmaceutical industry. Our commitment to exceptional service is evident due to our high repeat customer rate. It is the combination of scientific competency and the timely deliver of quality services that keep our clients coming back time and time again.
One of the biggest assets to the company is the diverse professional and educational backgrounds of the staff. We strive to provide our clients with services that meet and exceed their expectations by employing experienced, highly talented and well-trained scientists.
Cirrus is a wholly owned subsidiary of Bangalore, India based Kemwell Biopharma Pvt. Ltd., and is registered with the United States Food and Drug Administration (FDA) and is a cGMP compliant facility.